Document Detail

Artificial cardiac stimulation: a current view of physiologic pacemakers.
MedLine Citation:
PMID:  6850463     Owner:  NLM     Status:  MEDLINE    
Artificial pacing of the heart has evolved rapidly over the last 20 years; the physician can now implant "physiologic" pacemakers that preserve the natural order of atrial and ventricular systole. The commonly used pacemakers that pace only the ventricle can induce dizziness, fatigue and syncope and increase congestive heart failure. Physiologic pacemakers can eliminate many of these side effects, but they are more expensive, can be less durable and may induce arrhythmias. Physiologic pacing can provide the greatest benefit and cost-effectiveness when the particular functions of the device are matched to the specific needs of the patient.
M D Rosengarten; R C Chiu
Related Documents :
6542253 - Hypertrophic cardiomyopathy complicated by complete heart block. case report and review...
10845733 - Photosensitivity in juvenile myoclonic epilepsy.
2649733 - Helicopter transport of the patient receiving thrombolytic therapy.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Canadian Medical Association journal     Volume:  128     ISSN:  0008-4409     ISO Abbreviation:  Can Med Assoc J     Publication Date:  1983 Jun 
Date Detail:
Created Date:  1983-07-29     Completed Date:  1983-07-29     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  0414110     Medline TA:  Can Med Assoc J     Country:  CANADA    
Other Details:
Languages:  eng     Pagination:  1377-81     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Atrial Fibrillation / therapy
Blood Pressure
Cardiac Pacing, Artificial / adverse effects
Heart Failure / therapy
Pacemaker, Artificial* / adverse effects

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Coarctation of the aorta in an elderly man.
Next Document:  Nonspecific and selective stimulation of the immune system in the treatment of carcinoma in humans.